Journal for ImmunoTherapy of Cancer (Nov 2023)

232 NKG2D-based multi-specific CAR T-cells to overcome antigen escape and improve anti-tumor efficacy

Eytan Breman,
Benjamin Violle,
Celine Jacques-Hespel,
Jennifer Bolsee,
Jerome Marijsse

Affiliations

Eytan Breman: Celyad Oncology, Mont-Saint-Guibert, Belgium
Benjamin Violle: Celyad Oncology, Mont-Saint-Guibert, Belgium
Celine Jacques-Hespel: Celyad Oncology, Mont-Saint-Guibert, Belgium
Jennifer Bolsee: Celyad Oncology, Mont-Saint-Guibert, Belgium
Jerome Marijsse: Celyad Oncology, Mont-Saint-Guibert, Belgium

DOI: https://doi.org/10.1136/jitc-2023-SITC2023.0232
Journal volume & issue: Vol. 11, no. Suppl 1

Abstract

No abstracts available.

Published in Journal for ImmunoTherapy of Cancer

ISSN: 2051-1426 (Online)
Publisher: BMJ Publishing Group
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: https://jitc.bmj.com

About the journal